Response to neoadjuvant RCT as a predictor for overall survival in therapy of esophageal cancer

被引：0
|
作者：
Kirste, S. [1 ]
Mohammad, F. [1 ]
Murnik, M. [1 ]
Hoppner, J. [2 ]
Grosu, A. [1 ]
Nicolay, N. [1 ]
机构：
[1] Univ Freiburg, Fac Med, Med Ctr, Dept Radiat Oncol, Freiburg, Germany
[2] Univ Freiburg, Fac Med, Med Ctr, Dept Surg, Freiburg, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2021年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1231
引用
收藏
页码：S1017 / S1017
页数：1
相关论文
共 50 条
  • [1] Overall Survival Analysis of Neoadjuvant Chemoradiation Therapy and Esophagectomy for Esophageal Cancer
    Siddiqui, F. A.
    Atkins, K. M.
    Chennupati, S.
    Hunter, J. G.
    Dolan, J.
    Thomas, C. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S295 - S295
  • [2] Prognostic markers for response and overall survival in patients with esophageal adenocarcinoma treated with neoadjuvant therapy
    Leers, J. M.
    Lurje, G.
    Yang, D.
    Oezcelik, A.
    Hagen, J. A.
    DeMeester, S. R.
    DeMeester, T. R.
    Lenz, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Complete pathologic response to neoadjuvant chemoradiation is the only predictor of survival in patients with esophageal cancer
    Meredith, K. L.
    Weber, J.
    Siegel, E.
    McLoughlin, J.
    Taruga, K.
    Shah, N.
    Melis, M.
    Kelley, S.
    Karl, R.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 26 - 26
  • [4] Pre-Neoadjuvant Therapy Clinical Staging Predicts Overall Survival in Esophageal Cancer Patients with Pathologic Complete Response
    Gangi, A.
    Hoffe, S.
    Frakes, J.
    Almhanna, K.
    Pena, L.
    Fontaine, J.
    Blackham, A.
    Pimiento, J. M.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S151 - S151
  • [5] Overall survival analysis of neoadjuvant chemoradiotherapy and esophagectomy for esophageal cancer
    Siddiqui, Faisal A.
    Atkins, Katelyn M.
    Diggs, Brian S.
    Thomas, Charles R., Jr.
    Hunter, John G.
    Dolan, James P.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 5 (02) : 86 - 91
  • [6] Predicting response to neoadjuvant therapy in esophageal cancer
    Vallboehmer, Daniel
    Brabender, Jan
    Grimminger, Peter
    Schroeder, Wolfgang
    Hoelscher, Arnulf H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (09) : 1449 - 1455
  • [7] Exploring the proteome as a response predictor for rectal cancer undergoing neoadjuvant radiochemotherapy (RCT).
    Smith, FM
    Stephens, R
    Gaffney, E
    Crotty, P
    Petricoin, E
    Liotta, L
    Kennedy, J
    Reynolds, J
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 264S - 264S
  • [8] Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer?
    Imdahl, A
    Jenkner, J
    Ihling, C
    Rückauer, KD
    Farthmann, EH
    AMERICAN JOURNAL OF SURGERY, 2000, 179 (06): : 514 - 520
  • [9] Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer
    Tiesi, Gregory
    Park, Wungki
    Gunder, Meredith
    Rubio, Gustavo
    Berger, Michael
    Ardalan, Bach
    Livingstone, Alan
    Franceschi, Dido
    JOURNAL OF SURGICAL RESEARCH, 2017, 216 : 65 - 72
  • [10] Complete response to neoadjuvant chemoradiation therapy for esophageal cancer does not confer a survival advantage
    C. R. Schmidt
    J. L. Tarpley
    J. R. Roberts
    A. S. Pearson
    M. C. Kelley
    M. Ninan
    J. D. Berlin
    A. B. Chakravarthy
    R. D. Beauchamp
    N. B. Merchant
    Annals of Surgical Oncology, 2004, 11 : S55 - S55
12345